Celyad to Announce Full Year 2018 Financial Results and Host Conference Call

Celyad to Announce Full Year 2018 Financial Results and Host Conference Call

Celyad’s 2019 R&D Day Highlights shRNA Platform and Pipeline of Next-generation NKG2D-based and Off-the-Shelf Non-gene Edited CAR-T Candidates

Celyad’s 2019 R&D Day Highlights shRNA Platform and Pipeline of Next-generation NKG2D-based and Off-the-Shelf Non-gene Edited CAR-T Candidates

Celyad to Host R&D Day and Webcast on Monday, March 18 in New York City

Celyad to Host R&D Day and Webcast on Monday, March 18 in New York City

Celyad Appoints Anne Moore as Vice President Corporate Strategy

Celyad Appoints Anne Moore as Vice President Corporate Strategy

Discover our news

Upcoming events

May 8-9, 2019

Hanson Wade Allogeneic Cell Therapies Summit

May 16, 2019

World Advanced Therapies Congress 2019

May 17, 2019

Journées scientifiques du Cancéropôle Nord-Ouest

Discover all events

Press material

Dear Journalists,
Please find here all information background and material for your articles.
For any media request, please refer to the contacts below.
Join our press list
Press kit

Press kit

2.4 Mo

a

Press contacts

Celyad

Alexandrine Hazard, Corporate Communications Associate

+32 (0)10 39 41 58

LifeSci Advisors

Matt Middleman

NewCap (France)

Nicolas Merigeau, Pierre Laurent

+ 33(0)1 44 71 94 94

Comfi (Belgium)

Gunther De Backer, Sabine Leclercq

+32(0) 2 290 90 91